[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"biomarker:dsdna":3},{"name":4,"total":5,"recruiting":5,"trials":6},"dsDNA",3,[7,15,22],{"nct_id":8,"title":9,"phases":10,"status":12,"updated_at":13,"content_modified":14},"NCT06411249","A Study Describing the Efficacy and Safety of Belimumab Administered in Adult Participants With Early Systemic Lupus Erythematosus (SLE)",[11],"Phase 4","RECRUITING","2026-08-26T02:18:38.865010Z","2026-07-05T05:32:16.755824Z",{"nct_id":16,"title":17,"phases":18,"status":12,"updated_at":20,"content_modified":21},"NCT06839976","CD19-Directed Chimeric Antigen Receptor Autologous T Cells (CART19) for Lupus",[19],"Phase 1\u002FPhase 2","2026-08-26T02:17:20.511551Z","2026-05-05T02:35:31.669019Z",{"nct_id":23,"title":24,"phases":25,"status":12,"updated_at":27,"content_modified":28},"NCT07607964","A Study to Assess Adverse Events, How the Drug Moves Through the Body and Effectiveness of Intravenous Infusions and Subcutaneous Injections of ABBV-519 in Adult Participants With Systemic Lupus Erythematosus (SLE) or Rheumatoid Arthritis (RA)",[26],"Phase 1","2026-08-26T02:17:42.501124Z","2026-05-29T15:36:40.226566Z"]